日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma

输注后 PD-1+ CD8+ CAR-T 细胞可识别对非霍奇金淋巴瘤 CD19 CAR-T 细胞疗法有反应的患者

Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Yi Wang, Kelsi Reynolds, Robert M Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro Bezerra, Narendranath Epperla, Timothy J Voorhees, Jonathan Brammer, Adam S Kittai, David A Bond, Yazeed Sawalha, A

A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models

针对 CD74 的新型 CAR-T 细胞产品是临床前套细胞淋巴瘤模型的有效治疗方法

Wing Keung Chan, Jessica Williams, Kinnari Sorathia, Betsy Pray, Kaled Abusaleh, Zehua Bian, Archisha Sharma, Ian Hout, Shamama Nishat, Walter Hanel, Shelby L Sloan, Aneeq Yasin, Nathan Denlinger, Xiaoli Zhang, Natarajan Muthusamy, Sumithira Vasu, Marcos de Lima, Yiping Yang, Robert Baiocchi, Lapo A

Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma

高细胞毒性自然杀伤细胞与皮肤 T 细胞淋巴瘤患者预后不良有关

Bethany Mundy-Bosse, Nathan Denlinger, Eric McLaughlin, Nitin Chakravarti, Susan Hwang, Li Chen, Hsiaoyin Charlene Mao, David Kline, Youssef Youssef, Rebecca Kohnken, Dean Anthony Lee, Gerard Lozanski, Aharon G Freud, Pierluigi Porcu, Basem William, Michael A Caligiuri, Anjali Mishra